Projects per year
Fingerprint Dive into the research topics where Paul Harkin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 72 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
R1777CNR: Evalution of the role played by NFkB in mediating BRCA1 induced resistance to DNA damaging agents
01/08/2006 → 17/12/2019
Project: Research
R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Harrison, T., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., Prise, K., Salto-Tellez, M., Waugh, D., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R1311CNR: Functional characterisation of a novel BRCA1-mRNA splicing complex that is mutated in multiple cancers
01/08/2012 → 01/08/2018
Project: Research
R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Waugh, D., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., O'Sullivan, J., Prise, K., Salto-Tellez, M., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
Research Output
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
Hollis, R. L., Churchman, M., Michie, C. O., Rye, T., Knight, L., McCavigan, A., Perren, T., Williams, A. R. W., McCluggage, W. G., Kaplan, R. S., Jayson, G. C., Oza, A., Harkin, D. P., Herrington, C. S., Kennedy, R. & Gourley, C., 15 Aug 2019, In : Cancer. 125, 16, p. 2772-2781 10 p.Research output: Contribution to journal › Article
Open Access
File
2
Citations
(Scopus)
58
Downloads
(Pure)
Immune Activation by DNA Damage Predicts Response to Chemotherapy and Survival in Oesophageal Adenocarcinoma
Turkington, R., Knight, L., Blayney, J., Secrier, M., Douglas, R., Parkes, E., Sutton, E., Stevenson, L., McManus, D., Halliday, S., McCavigan, A., Logan, G., Walker, S., Steele, C., Perner, J., Bornscein, J., MacRae, S., Miremadi, A., mccarron, E., McQuaid, S. & 10 others, , 09 Mar 2019, In : Gut. 10 p.Research output: Contribution to journal › Article
Open Access
File
2
Citations
(Scopus)
145
Downloads
(Pure)
Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment
Campbell, A. M., Morris, M., Gallagher, R., Boyd, R., Carson, H., Harkin, D. P., Wielogorska, E., Elliott, C., Savage, K. I. & McIntosh, S. A., 22 Dec 2018, In : BMJ Open. 8, 12, p. e023115Research output: Contribution to journal › Article
Open Access
File
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer
Bankhead, P., Fernández, J. A., McArt, D. G., Boyle, D. P., Li, G., Loughrey, M. B., Irwin, G. W., Harkin, D. P., James, J. A., McQuaid, S., Salto-Tellez, M. & Hamilton, P. W., Jan 2018, In : Laboratory investigation. 98, p. 15-26Research output: Contribution to journal › Article
Open Access
File
11
Citations
(Scopus)
448
Downloads
(Pure)
The evolutionary landscape of colorectal tumorigenesis
The S:CORT Consortium, 31 Aug 2018, In : Nature Ecology and Evolution. 2, 10, p. 1661-1672 12 p.Research output: Contribution to journal › Article
16
Citations
(Scopus)
Prizes
European Business Award for Innovation
Paul Harkin (Recipient), 2014
Prize: Prize (including medals and awards)
Excellence in Innovation Industry Award
Paul Harkin (Recipient), 01 Jan 2010
Prize: Prize (including medals and awards)
Excellence in Technology Award
Paul Harkin (Recipient), 2014
Prize: Prize (including medals and awards)
Innovation Award UK National Champions
Paul Harkin (Recipient), 2014
Prize: Prize (including medals and awards)
MRC - Career Establishment Award
Paul Harkin (Recipient), 31 Jan 2002
Prize: Prize (including medals and awards)
Activities
Department of Health, Social Services and Public Safety (NI) (External organisation)
Paul Harkin (Member)Mar 2016 → …
Activity: Membership types › Membership of public/government advisory/policy group or panel
Department of Enterprise, Trade & Investment (External organisation)
Paul Harkin (Member)14 Aug 2015
Activity: Membership types › Membership of public/government advisory/policy group or panel
Journal of the National Cancer Institute (Journal)
Paul Harkin (Peer reviewer)2015 → …
Activity: Publication peer-review and editorial work types › Publication peer-review
Society of Gynecologic Oncology
Paul Harkin (Keynote/plenary speaker)2013 → …
Activity: Participating in or organising an event types › Participation in conference
world Companion Diagnostic Conference
Paul Harkin (Invited speaker)Nov 2012 → …
Activity: Participating in or organising an event types › Participation in conference
Press / Media
Targetable immune biology found in some patients with early-stage prostate cancer
25/03/2018
1 Media contribution
Press/Media: Research
Queens University leads largest study of its kind to transform Prostate cancer treatment.
23/10/2017
1 Media contribution
Press/Media: Research
Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
20/04/2017
1 Media contribution
Press/Media: Research
BBC International Television - News Headline "BRCA1: Hopes for women at high risk of breast and ovarian cancer"
28/03/2014
1 item of Media coverage
Press/Media: Research
Impact
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact